Stay updated on Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Footer updates show Revision: v3.3.3 and the HHS Vulnerability Disclosure link and Revision: v3.3.2 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:15:30.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Added a note that these publications are automatically filled in from PubMed and may not all pertain to the study. Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:22:42.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The government funding lapse notice/banner was removed from the page; this is an operational notice and the study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:46:37.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A new publication citation was added to the Publications section: Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure (Eur J Heart Fail, 2025 Nov 4).
    Difference
    0.1%
    Check dated 2025-11-11T02:09:55.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    No substantial content changes were detected in the study record; the core details such as title, NCT number, sponsor, eligibility criteria, and outcomes remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:38:31.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    Major change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T04:57:43.000Z thumbnail image

Stay in the know with updates to Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effect on Tissue Sodium in Heart Failure Clinical Trial page.